Biomarkers in Peripartum Cardiomyopathy-What We Know and What Is Still to Be Found.

shows selected endothelial miRs that may be significant for treating PPCM by decreasing angiogenesis via the decreased proliferation of endothelial cells or accelerated senescence of endothelial progenitor cells, increasing endothelial permeability, decreasing TIMPs, and increasing MMP activity that may cause excess inflammation and fibrosis, and additionally by activating macrophages [ 98 , 99 , 100 , 101 , 102 ].

also in 13,097 other papers